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Abstract: 
 
Peptaibols are an intriguing class of fungal metabolites due both to their wide range of 
reported bioactivities and to the structural variability that can be generated by the exchange of 
variable amino acid building blocks. In an effort to streamline the discovery of structurally 
diverse peptaibols, a mass spectrometry surface sampling technique was applied to screen the 
chemistry of fungal cultures in situ. Four previously undescribed peptaibols, all containing a 
rare threonine residue, were identified from a fungal culture (MSX53554), which was identified 
as Nectriopsis Maire (Bionectriaceae, Hypocreales, Ascomycota). These compounds not only 
increased the known threonine-containing peptaibols by nearly 20%, but also, the threonine 
residue was situated in a unique place compared to the other reported threonine-containing 
peptaibols. After the initial in situ detection and characterization, a large-scale 
solid fermentation culture was grown. The four peptaibols were isolated and characterized by 
mass spectrometry. In addition, one of the peptaibols was fully characterized by NMR and amino 
acid analysis using Marfey's reagent and exhibited moderate in vitro anticancer activity. 
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1. Introduction 
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Peptaibols are a class of fungal secondary metabolites that are typically comprised of 5–20 
amino acid units, including one to several α-aminoisobutric acid (Aib) residues, and have an 
acylated N-terminus with an amino-alcohol C-terminus (Degenkolb et al., 2003, Degenkolb and 
Bruckner, 2008, Neumann et al., 2015, Otto et al., 2016, Toniolo and Brückner, 2007, Toniolo 
and Brückner, 2009, Whitmore and Wallace, 2004). These small peptides have been reported to 
possess a wide variety of bioactivities, such as antimicrobial (Figueroa et al., 2013), anthelmintic 
(Schiell et al., 2001, Thirumalachar, 1968), and cytotoxic (He et al., 2006). As part of a 
multidisciplinary program to identify new anticancer leads from nature (Ayers et al., 2012, 
Figueroa et al., 2013, Kinghorn et al., 2016), a protocol was implemented to monitor the 
chemistry of fungal cultures in situ using a recently described droplet–liquid microjunction–
surface sampling probe (droplet–LMJ–SSP) coupled to an ultraperformance liquid 
chromatography–high resolution mass spectrometry (UPLC–HRMS) system (Kertesz and Van 
Berkel, 2010, Paguigan et al., 2016, Sica et al., 2016b, Sica et al., 2015, Sica et al., 2016c). 
 
The droplet–LMJ–SSP system is a modified autosampler with the ability to manually control 
the syringe to act as a surface sampling probe. This system is designed to perform 
microextractions on the surface of a sample and directly inject the extract into LC-MS (Kertesz 
and Van Berkel, 2010, Kertesz and Van Berkel, 2013, Kertesz and Van Berkel, 2014). Recently, 
this technique has been applied towards in situ analyses of fungal and plant metabolites with 
various goals, such as dereplication of fungal cultures (Sica et al., 2015), spatial and temporal 
mapping of the biosynthesis of targeted leads in fungal cultures (Paguigan et al., 2016, Sica 
et al., 2016b, Sica et al., 2016c), and the characterization of complex mixtures in a suite of plant 
tissues (Sica et al., 2016a). A major benefit of this technique is the ability to monitor the 
biosynthesis of fungal secondary metabolites, both with respect to space and time, without 
having to extract the entire culture. Recently, Ifa and colleagues demonstrated the detection of 
peptaibols from fungal cultures using ambient ionization mass spectrometry (Tata et al., 2015); 
however, there has yet to be a protocol reported for both the detection and characterization of 
peptaibols from fungal cultures in situ. 
 
Since peptaibols are readily identified by mass spectrometry due to a few characteristic signals, 
an in situ mass spectrometry technique possesses great potential for early stage prioritization. 
When using electrospray ionization (ESI), peptaibols often undergo in-source fragmentation, 
effectively splitting the compound into two or more product ions (b-type and y-type ions) 
adjacent to any proline residues that are present (Ayers et al., 2012, Degenkolb et al., 2003). 
Subsequently, high resolution tandem mass spectrometry (HRMS/MS) on each fragment 
provides the accurate masses of each amino acid as they cleave sequentially. Due to these 
characteristics, the droplet–LMJ–SSP can not only detect the presence of peptaibols, but also 
allows for in situ characterization (Sica et al., 2016a) of them prior to performing any 
fermentation and isolation procedures (Ayers et al., 2012, Figueroa et al., 2013, Rivera-Chávez 
et al., 2017). 
 
During the in situ evaluation of the biosynthesis of fungal metabolites in cultures (Sica et al., 
2015), a series of novel, threonine-containing peptaibols were identified, which was notable 
because only a small percentage of peptaibols are known to contain a threonine(Thr) residue. 
According to the online peptaibiotics database, as of 2017 (Neumann et al., 2015), only about 
1.5% (21 of 1390) of peptaibols and peptaibol-like compounds contained threonine, including 
those with antibiotic properties (emerimicins and zervamicins (Rinehart et al., 1981)) and with 
anthelmintic activity (cephaibols (Schiell et al., 2001)). Of these peptaibols from the database 
(Neumann et al., 2015), all are either 16- or 17-residue long sequences with the Thr in the sixth 
position of the amino acid sequence (Andersson et al., 2009, Rinehart et al., 1981, Schiell et al., 
2001, Sharman et al., 1996). The peptaibols reported herein contained the Thr residue in position 
10 of a sequence that was only eleven residues long. Upon in situ detection and identification of 
Thr-containing peptaibols, a larger scale fermentation of the fungal culture was prepared and 
extracted to isolate and fully characterize their structures using HRMS/MS, NMR, and Marfey's 
analysis (Bhushan and Brückner, 2004, Bhushan and Brückner, 2011, Kjer et al., 2010, Marfey, 
1984). Additionally, one of the isolated peptaibols showed moderate cytotoxicity. 
 
2. Results and discussion 
 
2.1. In situ analysis of fungal metabolites 
 
Traditionally, the structures of peptaibols are characterized by mass spectrometry. This technique 
allows for the assembly of the amino acids in a molecule by analysis of the sequential 
fragmentation of b-type and y-type ions generated in-source. However, this method does not 
allow the differentiation between isobaric amino acids (e.g., leucine and isoleucine, etc.) and 
enantiomers (i.e., D or L). Given the ability to study peptaibols by mass spectrometry, coupled 
with their interesting biological activities (Figueroa et al., 2013, He et al., 2006, Schiell et al., 
2001, Thirumalachar, 1968), we sought to study fungal cultures in situ toward the discovery of 
peptaibols by using the droplet–LMJ–SSP, (Kertesz and Van Berkel, 2010, Paguigan et al., 
2016, Sica et al., 2016b, Sica et al., 2015, Sica et al., 2016c). The fungal culture, coded 
MSX53554, which was identified as Nectriopsis Maire (Bionectriaceae), was readily noted as a 
peptaibol producer based on the mass spectral data (Fig. 1). The key indicators of peptaibols in 
the HRMS and MS/MS spectra were the presence of in-source fragments around the proline 
residue, the presence of Aib residues, a C-terminus that was reduced to an alcohol, and an 
acetylated N-terminus. Upon further analysis of the MS/MS data (Fig. 1C), it was determined 
that strain MSX53554 biosynthesized peptaibols with a Thr residue, which was quite rare 
(Degenkolb et al., 2003, Degenkolb and Bruckner, 2008, Neumann et al., 2015, Whitmore and 
Wallace, 2004). 
 
2.2. Isolation 
 
A solid phase culture of fungal culture MSX53554 was prepared for the purpose of isolation and 
identification of the peptaibols detected via the surface sampling system. The culture was 
extracted and subjected to fractionation by normal phase flash chromatography. The peptaibol-
containing fraction was further processed by reverse phase HPLC to isolate the peptaibols. While 
compound 1 was readily isolated from the fraction, compounds 2–4 co-eluted, appearing as a 
single peak. Initially thought to be a single compound, the mixture of 2–4 was run on LC-MS to 
begin the characterization process. The full scan MS quickly showed the presence of isomeric 
peptaibols by the detection of two in-source fragment pairs of m/z 510/571 and m/z 496/585 
(Fig. 2). 
 
 
Fig. 1. (A) The chromatographic data obtained from the surface sampling screening protocol. (B) 
The mass spectrum for the peak at 5.66 min, indicating the presence of a peptaibol by in-source 
fragments for the b-type (510.3291) and y-type (585.3975) ions. (C) The tandem mass 
spectrum from each fragment (m/z 510.3291, top; m/z 585.3975, bottom), providing enough 
information to begin characterizing the structure from in situ data; all the fragments connected by 
arrows in this panel are b-type ions. 
 
To further purify this mixture, analytical HPLC of the mixture of 2–4 was performed, and the 
extracted ion chromatograms (±5 ppm) of the in-source fragments were monitored to optimize 
the separation of the isomers (Fig. S4). A 40% acetonitrile isocratic method revealed three 
isomeric peptaibols and provided the best separation of these compounds for the isolation of pure 
compounds. Enough material for characterization by HRMS and MS/MS was purified via semi-
preparatory HPLC. 
 
 
Fig. 2. Two pairs, colored red and black, of in-source fragments for m/z 1080.7039 that indicated 
co-eluting isomers. 
 
2.3. Structure elucidation 
 
The complete structure of compound 1 was elucidated using three orthogonal approaches: (1) 
MS/MS fragmentation patterns to determine the amino acid sequence; (2) derivatization with 
Marfey's reagent to identify the chirality of each amino acid; and (3) 2D NMR experiments to 
confirm the structure. However, for the positionally isomeric compounds (2–4), their structure 
elucidation was limited to MS/MS analysis due to paucity of the samples. 
 
2.3.1. Mass spectrometry 
 
In-source fragmentation of compound 1 resulted in two ions that were further fragmented by 
higher-energy collisional dissociation (HCD), providing high resolution fragments that indicated 
which amino acids were present. Furthermore, the b-type ions were most abundant, which 
accelerated the identification of the sequence. The spectra obtained from this analysis of a pure 
compound isolated from a large-scale culture matched the spectra previously obtained via the 
screening process of a droplet from the culture in a Petri dish. This confirmed the viability of the 
screening process for in situ detection and characterization of peptaibols. It also demonstrated 
that the fungal culture continued to biosynthesize this unique class of threonine-containing 
peptaibols during the scale-up process. 
 
The pseudomolecular ion [M+H]+ of the intact peptaibol 1 was observed at m/z 1094.7186, 
which confirmed the molecular formula of C53H95N11O13 (Δ m/z 0.2 ppm). The two diagnostic 
in-source fragments were m/z 510.3264 and m/z 585.3966, suggesting molecular formulae of 
C25H43N5O6 and C28H52N6O7, respectively (Fig. S5). As is typical, the fragmentation was 
presumed to be adjacent to the proline residue, which was later confirmed by NMR experiments. 
Since the isobaric amino acid isomers cannot be differentiated by MS, some amino acid 
identifications remained ambiguous (e.g., Lxx indicates either Leu or Ile; Vxx indicates Val or 
Iva). HCD fragmentation of m/z 510.3264 resulted in the sequential losses of Aib (85.0512), Lxx 
(113.0841), Ala (71.0368), and Aib (85.0527). The final fragment at m/z 156.1016 was attributed 
to Lxx and the presence of an acetylated N-terminus, a feature that is commonly observed for 
peptaibols (Degenkolb et al., 2003, Neumann et al., 2015). HCD fragmentation of m/z 585.3966 
resulted in the sequential losses of Lxxol (m/z 117.1153), Thr (101.0477), Gly (57.0216), and 
Vxx (99.0682). The diagnostic fragment m/z 211.1438 was attributed to Pro-Lxx with the Pro 
presumed to be adjacent to the cleavage point. At this point, the sequence for compound 1was 
identified as Ac-Lxx1-Aib2-Ala3-Lxx4-Aib5-Pro6-Lxx7-Vxx8-Gly9-Thr10-Lxxol. 
Compounds 2 (Fig. S6), 3 (Fig. S7), and 4 (Fig. S8) were analyzed in similar fashion (Table 1). 
 
Table 1. The high resolution tandem mass spectrometry (HRMS/MS) data for peptaibols 1–4. 
Compound [M+H]+ In-source Fragmenta HRMS/MS of in-source fragmentb 
Necthreonin A (1) 1094.7196 510.3264 425.2752 312.1911 241.1543 156.1016 
585.3966 468.2813 367.2336 310.2120 211.1438 
Necthreonin B (2) 1080.7018 510.3282 425.2751 312.1911 241.1543 156.1015 
571.3807 454.2653 353.2177 296.1963 211.1438 
Necthreonin C (3) 1080.7015 496.3122 411.2595 312.1910 241.1540 156.1017 
585.3962 450.2705 367.2333 310.2118 211.1437 
Necthreonin D (4) 1080.7010 496.3119 411.2594 298.1752 277.1389 156.1015 
585.3959 468.2806 367.2329 310.2118 211.1435 
aIn this column, the top number indicates the b-type ion fragment and the bottom number indicates the y-type ion 
fragment. 
bIn this column, all fragments are the b-type ions after applying MS/MS to the in-source fragment in the adjacent 
column. 
 
2.3.2. Amino acid analysis using Marfey's reagent 
 
The absolute configuration of the individual amino acids in 1 was assigned by acid hydrolysis 
and subsequent derivatization with Nα-(2,4-dinitro-5-fluorophenyl)-L-alaninamide [Marfey's 
reagent (Bhushan and Brückner, 2004, Bhushan and Brückner, 2011)]. Traditionally, this method 
compares the retention time of the amino acid-Marfey's derivatives with those of derivatized D 
and L standards for each amino acid, using LC-UV to monitor the eluents at a wavelength of 
340 nm (Ayers et al., 2012, Figueroa et al., 2013, Rivera-Chávez et al., 2017). Compound 1 was 
examined in a similar fashion, but also incorporated MS to add mutually supportive data to this 
confirmation (Table S1). For instance, the chromatographic method resulted in both D-Val and 
L-Leu eluting at the same time (Table S1). Thus, UV data alone would not allow for 
differentiating the two without optimizing the chromatography and re-running the samples. 
Furthermore, the use of MS was beneficial over UV alone, since the α-substituted amino acids 
(Aib, Iva, etc.) were over a magnitude lower in UV and MS signal. Thus, the ability to perform 
extracted ion chromatograms (±5 ppm) provided a more confident comparison of retention times 
with the standards without the need to increase the sample's concentration and perform re-
analysis. 
 
Additionally, the data showed that there was both Leu and Ile residues present, which was 
something that could not be differentiated for the intact peptaibol by MS. Based on the 
integration under each peak, it was determined that the Leu peak was about three times larger 
than that of the Ile peak. Thus, one of the four MS fragments that indicated a loss of Lxx 
(m/z 113 for Lxx and 117 for Lxxol) must be an Ile residue. 
 
2.3.3. Nuclear magnetic resonance 
 
The structure of peptaibol 1, including the position of the Ile residue, was confirmed by 1D 
(Fig. S9) and 2D NMR (Table 2). A TOCSY experiment readily identified the protonated amide 
associated with each amino acid residue (Fig. S10). As expected, the Pro, Aib, and Iva residues 
do not present any correlations due to the lack of protons on the α-carbon. The Ile residue was 
distinguished from the Leu residues by the integration of the α-H (H), β-H (H), γ1-H (2H), γ2-H 
(3H), and δ-H (3H), the TOCSY correlations (Fig. S11A) of the NH (δH 7.66) with the α-H 
(δH 4.17), β-H (δH 1.95), γ1-H (δH 1.35 and 1.57), γ2-H (δH 0.97), and δ-H (δH 0.86), and the 
HMBC correlations (Fig. S11B) of the NH (δH 7.66) with the α-C (δC59.0) and β-C (δC 36.8). 
The position of the Ile was determined by the HMBC correlations of the NH (δH 7.66, Ile4) with 
the carbonyl of Ala3 (δC 174.6) and the NH (δH 8.06, Aib5) with the carbonyl of Ile4 (δC 173.6). 
 
Table 2. NMR spectroscopic data for compound 1 (1H, 700 MHz and 13C 175 MHz in CDCl3).a  
δC type δC mult. (J in Hz) HMBC (nJHC) TOCSY (nJHH) 
Ac 
CO 173.4 C – – – 
Me 23.0 CH3 2.11, s CO – 
Leu1 
CO 174.5 C – – – 
NH – – 7.99 – – 
α 55.9 CH 3.91, td (8.0, 3.1) CO, β β, γ, δ′ 
β 40.0 CH2 1.68, m CO, α, γ, δ, δ′ α, γ, δ′ 
γ 24.9 CH 1.74, m CO, α, β, δ, δ′ α, β, δ, δ′ 
δ 22.4 CH3 0.94, d (6.5) β, γ, δ′ α, β, γ, δ′ 
δ′ 22.4 CH3 0.97, d β, γ, δ α, β, γ, δ 
Aib2 
CO 176.0 C – – – 
NH – – 8.23, s CO (L1), CO, α, β – 
α 56.6 C – – – 
β1 27.7 CH3 1.43, s CO, α, β2 – 
β2 23.4 CH3 1.51, s CO, α, β1 – 
Ala3 
CO 174.6 C – – – 
NH – – 7.38, d (6.5) CO (U2), α, β α, β 
α 51.6 CH 4.21, m CO, β NH, β 
β 17.5 CH3 1.51, d (7.0) CO, α NH, α 
Ile4 
CO 173.6 C – – – 
NH – – 7.66, d (7.8) CO (A3), α, β α, β, γ1, γ2, δ 
α 59.0 CH 4.17, t (7.4) CO, β, γ1, γ2 NH, β, γ1, γ2, δ 
β 36.8 CH 1.95, m α, β, γ1, γ2, δ NH, α, γ1, γ2, δ 
γ1 26.0 CH2 1.35, m 
1.57, m 
β, γ2, δ NH, α, β, γ1, γ2, δ 
γ2 15.7 CH3 0.97, d, 
overlapped 
α, β, γ1 NH, α, β, γ1 
δ 11.5 CH3 0.86, t (7.4) β, γ1 β, γ1, γ2, δ 
Aib5 
CO 173.8 C – – – 
NH – – 8.06, s CO (I4), α, β2 – 
α 56.9 C – – – 
β1 26.4 CH3 1.48, s CO, α, β2 – 
 
δC type δC mult. (J in Hz) HMBC (nJHC) TOCSY (nJHH) 
β2 23.5 CH3 1.55, s CO, α, β1 – 
Pro6 
CO 175.7 C – – 
 
α 63.6 CH 4.36, t (7.5) CO, β, γ, δ β, γ, δ 
β 28.9 CH2 1.79, m 
2.23, m 
CO, α, γ, δ α, β, γ, δ 
γ 26.4 CH2 1.95, m 
2.12, m 
α, β, δ α, β, γ, δ 
δ 49.3 CH2 3.71, m β, γ α, β, γ 
Leu7 
CO 175.7 C – – – 
NH – – 7.73, d (6.4) CO (P6), α, β α, β, γ, δ, δ′ 
α 55.5 CH 4.06, dd (7.3) CO, β, γ NH, β, γ, δ, δ′ 
β 39.4 CH2 1.88, m CO, α, γ, δ NH, α, γ, δ, δ′ 
γ 25.0 CH 1.74, m CO, α, β NH, α, β, δ, δ′ 
δ 22.1 CH3 0.92, m Nothing α, β, γ, δ′ 
δ′ 22.6 CH3 0.98, m Nothing α, β, γ, δ 
Iva8 
CO 178.4 C – – – 
NH – – 7.95, s CO (L7), CO α, β2 – 
α 59.7 C – – – 
β1 25.3 CH2 2.37, dd (7.5) 
1.78, m 
CO α, β2, γ β1, γ 
β2 23.1 CH3 1.47, s CO α, β1 – 
γ 7.1 CH3 0.79, t (7.4) α, β1 β1 
Gly9 
CO 171.3 C – – – 
NH – – 7.82, d (7.7) CO (J8), α, α′ α, α′ 
α 44.9 CH2 3.70, m CO NH, α′ 
α′ 44.9 CH2 4.00, dd (16.7, 4.6) CO NH, α 
Thr10 
CO 171.4 C – – – 
NH – – 7.81, d (7.7) CO (G9), α, β α, β, γ, OH 
α 63.5 CH 4.11, t (6.4) CO, β, γ NH, β, γ, OH 
β 67.0 CH 4.30, m (6.5) γ NH, α, γ, OH 
γ 20.0 CH3 1.35, d (6.4) α, β NH, α, β, OH 
OH – – 4.75, d (7.7) β, γ NH, α, β, γ 
Leuol 
NH – – 6.95, d (9.1) CO (T10) α, β1, β2, γ, δ, OH 
α 50.1 CH 4.12, m 
 
NH, β1, β2, γ, δ, OH 
β1 39.7 CH2 1.22, m 
1.54, m 
β1, γ, δ NH, α, β2, γ, δ 
β2 65.8 CH2 3.55, m 
3.64, t (8.8) 
α, β1 NH, α, β1, β2, γ, δ, OH 
γ 24.9 CH 1.68, m α, β1 NH, α, β1, δ 
δ 22.1 CH3 0.90, m β1, γ NH, α, β1, β2, γ 
OH – – 3.85, t β2 NH, α, β1, β2, γ 
aL = Leu, U = Aib, I = Ile, A = Ala, P = Pro, J = Iva, G = Gly, T = Thr. 
 
Threonine was also confirmed via NMR, by integration of the α-H (H), β-H (H), and γ-H (3H) 
along with the OH. The TOCSY signals correlated (Fig. S11C) from the NH (δH 7.81) to the α-H 
(δH 4.11), β-H (δH 4.30), γ-H (δH 1.35), and OH (δH 4.75). Furthermore, the coupling constants of 
the α-H (J = 6.4 Hz), β-H (J = 6.5 Hz), and γ-H (J = 6.4 Hz) were all in agreement with each 
other. The HMBC data correlated (Fig. S11C) the NH (δH 7.81) with the α-C (δC 63.5.0) and β-C 
(δC 67.0), as well as with the carbonyl of the adjacent Gly (171.3) residue. Further confirming 
the presence of the threonine, the OH displayed correlations to the α-H (δH 4.11), β-H (δH 4.30), 
γ-H (δH 1.35), and NH (δH 7.81) and to the β-C (δC 67.0) and γ C (δC 20.0) in the TOCSY and 
HMBC spectra, respectively. The position of the Thr was determined by the HMBC correlations 
of the NH (δH 7.81, Thr10) with the carbonyl of Gly9 (δC 171.3) and the NH (δH 6.95, Leuol) with 
the carbonyl of Thr10(δC 171.4). Interestingly, this is the first reported case where the Thr residue 
was in the tenth position of an 11-residue long sequence. In all other Thr-containing peptaibols, 
this residue was located in the sixth position of a 16- or 17-residue peptaibol (Andersson et al., 
2009, Neumann et al., 2015, Rinehart et al., 1981, Schiell et al., 2001, Sharman et al., 1996). All 
other amino acids and their respective positions were determined (Fig. 3) via TOCSY, HMBC, 
and NOESY in a similar fashion (Table 2), and compound 1 was ascribed the trivial name 
necthreonin A. 
 
 
Fig. 3. The overall structure for compound 1 was confirmed by TOCSY, HMBC, and NOESY 
NMR. This figure illustrates key correlations. 
 
2.3.4. Sequence determination 
 
Compounds 2–4, which were ascribed the trivial names necthreonin B, necthreonin C, and 
necthreonin D, respectively, were characterized only by HRMS/MS due to the paucity of sample. 
Fortunately, their fragmentation patterns were very similar to that of compound 1, with only one 
amino acid difference for each. Compared to compound 1, compound 2 had Aib8 instead of Iva8, 
compound 3 presumably had Val4 instead of Ile4, and compound 4 had Ala2 instead of 
Aib2 (Table 3). 
 
Table 3. The proposed sequences of the four peptaibols from fungal culture MSX53554, 
Nectriopsis sp. The amino acid residues that are in bold were the positions that differed from 
compound 1. For compounds 2–4, the structures of isobaric amino acids (underlined) could not 
be confirmed due to paucity of sample and are proposed based on biosynthetic considerations 
relative to the fully characterized 1. Those amino acids could also be labeled as Lxx, indicating 
Leu or Ile, and Vxx, indicating Val or Iva. 
Compound Sequence 
Necthreonin A (1) Ac–Leu–Aib–Ala–Ile–Aib–Pro–Leu–Iva–Gly–Thr–Leuol 
Necthreonin B (2) Ac–Leu–Aib–Ala–Ile–Aib–Pro–Leu–Aib–Gly–Thr–Leuol 
Necthreonin C (3) Ac–Leu–Aib–Ala–Val–Aib–Pro–Leu–Iva–Gly–Thr–Leuol 
Necthreonin D (4) Ac–Leu–Ala–Ala–Ile–Aib–Pro–Leu–Iva–Gly–Thr–Leuol 
 
While only compound 1 was confirmed by NMR and derivatization with Marfey's reagent, the 
amino acids for compounds 2–4 were presumed to contain the same isomeric ratios. For instance, 
Ile in position 7 for compound 1 was presumed to be Ile in position 7 for compounds 2 and 4 
rather than Leu. The Val in position 4 for compound 3 was presumed to be Val, as opposed to 
Iva, due to its structural similarity to Ile (Fig. 4A). This assumption is based on similar instances 
observed for the other compounds. For example, the Iva in position 8 for compound 1 was found 
to be Aib in compound 2, which is only a methylenedifferent (Fig. 4B). Similarly, the Ala in 
position 2 for compound 4 is only a methylene different from the Aib in position 2 for compound 
1 (Fig. 4C). However, we stress that the identification of the isobaric amino acids could not be 
confirmed for compounds 2–4 (i.e., Val4 instead of Iva4 for compound 3), even though the 
structural trends between the compounds supported these hypotheses. 
 
 
Fig. 4. The dashed lines indicate the difference of CH2 between (A) position 4 for 
compounds 1 and 3, (B) position 8 for compounds 1 and 2, and (C) position 2 for 
compounds 1 and 4. The inclusion of the dashed line represents compound 1 in all cases above. 
 
2.4. Anticancer bioactivity 
 
The purified peptaibols (1–4 (Fig. S12)) were tested against human melanoma cancer 
cells(MDA-MB-435), human breast cancer cells (MDA-MB-231), and human ovarian cancer 
cells (OVCAR3). Compound 1 was moderately active against the human cancer cell lines, with 
IC50 values ranging between 15 and 23 μM (Table 4); the other three peptaibols were inactive, 
with IC50 values > 25 μM. 
 
Table 4. The bioactivity for the four peptaibols in the breast (MDA-MB-435 and MDA-MB-
231) and ovarian (OVCAR3) cancer cell lines. 
Compound IC50 (μM) 
MDA-MB-435 MDA-MB-231 OVCAR3 
Necthreonin A (1) 23.3 15.1 22.6 
Necthreonin B (2) >25 >25 >25 
Necthreonin C (3) >25 >25 >25 
Necthreonin D (4) >25 >25 >25 
taxol 0.004 0.011 0.006 
 
3. Conclusion 
 
Using the droplet–LMJ–SSP, it is feasible to scan fungal cultures in situ for compounds of 
interest, thereby prioritizing samples for scale-up fermentations. The droplet–LMJ–SSP coupled 
to UPLC–HRMS provided the chromatographic resolution necessary to separate mixtures and 
characterize fungal secondary metabolites in situ. By performing this screening protocol, a 
fungal culture was rapidly identified as a peptaibol-producing fungus, and subsequently, four 
new threonine-containing peptaibols were characterized (Table 2), thereby increasing the number 
of these known in the literature by nearly 20%. 
 
NMR, HRMS, and Marfey's analysis supported the screening results and confirmed the 
structures of the new compounds. The inclusion of HRMS data into the Marfey's analysis 
provided mutually supportive data and removed any uncertainty that remained from using UV 
data alone. Ultimately, this study incorporated advanced mass spectrometry techniques to 
discover and elucidate new bioactive compounds from fungi. 
 
4. Experimental 
 
4.1. General experimental procedures 
 
In situ sampling of fungal cultures was performed by the droplet–liquid microjunction–surface 
sampling probe (droplet–LMJ–SSP). This system was constructed as detailed previously 
(Kertesz and Van Berkel, 2010, Kertesz and Van Berkel, 2013, Sica et al., 2015). The droplet–
LMJ–SSP was coupled to the Waters Acquity ultraperformance liquid chromatography (UPLC) 
and Thermo QExactive Plus mass spectrometry system. The UPLC separations were performed 
on an Acquity BEH C18 column (50 mm × 2.1 mm i.d., 1.7 μm) equilibrated at 40 °C and 
operated at a flow rate of 0.3 ml/min. The mobile phase consisted of Fisher Optima LC−MS 
grade CH3CN H2O (acidified with 0.1% formic acid), starting at 15% CH3CN and increasing 
linearly to 100% CH3CN over 8 min. The system was held at 100% CH3CN for 1.5 min before 
returning to starting conditions for re-equilibration. The photodiode array detector (PDA) was set 
to acquire from 200 to 500 nm with 4 nm resolution. 
 
HPLC separations were performed using Varian ProStar HPLC system connected to a ProStar 
335 PDA with UV detection set at 210 and 254 nm. Preparative HPLC purifications were 
performed on an Atlantic T3 C18 column (250 × 19 mm i.d., 5 μm) at a flow rate of 15.0 ml/min. 
The semi-preparative HPLC purification of isomers was performed on a YMC C18 column 
(250 × 10 mm i.d., 5 μm) at a flow rate of 4.7 ml/min. Flash column chromatography was carried 
out with a Teledyne ISCO Combiflash Rf connected to ELSD and PDA detectors with UV 
detection set at 200–400 nm. 
 
The NMR data were collected on an Agilent 700 MHz NMR spectrometer (Agilent 
Technologies, Inc., Santa Clara, CA, USA) equipped with a cryoprobe operating at 700 MHz and 
175 MHz for 1H and 13C, respectively. The chemical shift values were referenced to the residual 
solvent signals for CDCl3 (δH/δC 7.26/77.16). HRMS data were collected using a Thermo 
QExactive Plus mass spectrometer (ThermoFisher, San Jose, CA, USA) in positive electrospray 
ionization mode coupled to a Waters Acquity UPLC system (Waters Corp., Milford, MA, USA). 
The spray voltage was set to 4.0 kV, resulting in the in-source fragmentation of the precursor 
ions for the peptaibols. The higher-energy collisional dissociation (HCD) fragmentation used a 
normalized collision energy of 25 for all compounds to obtain the tandem mass spectrometry 
(MS/MS) data of each in-source generated fragment. In general, the b-ions were the predominant 
fragment ions. 
 
Reference standards of amino acids and Marfey's reagent were obtained from Sigma-Aldrich (St. 
Louis, MO, USA). All other reagents and solvents were obtained from Fisher Scientific and were 
used without further purification. 
 
4.2. In situ chemical analysis of fungal cultures 
 
Mass spectrometry monitoring of fungal secondary metabolites in situ can address important 
ecological information that could be lost via traditional extraction process (Sica et al., 2016b, 
Sica et al., 2015, Sica et al., 2016c). To better understand the fungal metabolites biosynthesized 
in a living axenic culture, we analyzed a culture of strain MSX53554 by the droplet–LMJ–SSP 
system. Briefly, the culture was grown in a Petri dish containing nutrient agar, such as potato 
dextrose agar (Difco), and allowed to grow for 3 weeks prior to analysis. 
 
4.3. Identification of fungal strain (MSX53554) 
 
Mycosynthetix fungal strain MSX53554 was isolated from leaf litter collected in a baboon 
sanctuary in 1991 by Dr. Barry Katz. Identification of strain MSX53554 was based on 
morphological, cultural, and molecular data. Colonies of strain MSX53554 on potato dextrose 
agar were fast growing, reaching a diameter of 30 mm in 3 weeks; milky white, reverse colony 
of same color (Fig. S1A); conidiophores branched, phialidic; conidia oblong to short cylindrical, 
in slimy heads, cyanophilic (blue in aqueous cotton blue stain) (Fig. S1B & C). Thus, based on 
morphological examination of the strains grown on potato dextrose agar, we were able to 
identify the strain as belonging to the genus Nectriopsis Maire (Zare and Gams, 2016). 
 
Molecular identification followed protocols that have been described in detail recently (Raja et 
al., 2017b). Briefly, DNA was extracted from the fungal culture using a Zymo Research 
Fungal/Bacterial DNA Extraction Kit. For PCR, we sequenced portions of three gene regions: 
ITS1, 5.8S, ITS2 rDNA (Internal transcribed spacer region), partial 28S rDNA large subunit 
(LSU), and partial fragment of translation elongation factor 1-alpha (tef1). The ITS region was 
PCR amplified using primers ITS5 and ITS4 (White et al., 1990), the partial LSU region was 
amplified using LROR and LR6 (Vilgalys and Hester, 1990), while the tef1region, specifically 
intron 4 in combination with intron 5, which is useful for species-level identification, was 
obtained using primer combinations 983F/728F and 2218R (Carbone and Kohn, 1999, Jaklitsch 
et al., 2005). Protocols for Sanger sequencing were as outlined previously (Raja et al., 2015, Raja 
et al., 2017a). All three sequences were subject to a BLAST search in NCBI GenBank to verify 
their identity. BLAST search was evaluated only with published, authentic sequences. Based on 
a BLAST search of NCBIs GenBank nucleotide database, the closest hit using the ITS sequence 
was Nectriopsis rexiana (≡ Verticillium rexianum) culture-collection CABI:IMI320287 
(GenBank JQ647443; Identities = 492/500 (98%), Gaps = 1/1122 (0%)), followed by Nectriopsis 
exigua strain G.J.S. 98-32 (GenBank HM484865.1; Identities = 462/463 (99%), Gaps = 0/463 
(0%). The LSU data showed high sequence similarity to Nectriopsis violacea strain CBS 424.64 
(GenBank AY489719; Identities = 994/1004 (99%), Gaps = 0/1004 (0%)), followed by 
Nectriopsis violacea strain MUCL40056 (GenBank AF193242; Identities = 956/969 (99%), 
Gaps = 2/969 (0%). A BLAST search with partial tef1 region also showed a high sequence 
similarity with Nectriopsis exigua strain G.J.S. 98-32 (GenBank HM484852; 
Identities = 834/837 (99%), Gaps = 0/837(0%). To elucidate the phylogenetic placement of strain 
MSX53554, we downloaded ITS and LSU sequences of Nectriopsis from a recent morphological 
and molecular study of Nectriopsis spp. (Zare and Gams, 2016). Since the ITS and LSU 
sequences were unequally available for different strains, we did not combine the two datasets. 
Multiple sequence alignment were performed using MUSCLE (Edgar, 2004) for separate ITS 
and LSU datasets, and phylogenetic analysis was performed using Maximum Likelihood 
(PHYML) with General Time Reversible model employing 1000 bootstrap searches in Seaview 
v.4.5.4 (Gouy et al., 2010). In the ITS phylogeny, MSX53554 was grouped with Nectriopsis 
exigua strain G.J.S. 98-32 with 87% PHYML bootstrap support (Fig. S2). The LSU phylogeny 
also showed that MSX53554 grouped with Nectriopsis exigua strain G.J.S. 98-32 with 72% 
PHYML bootstrap support (Fig. S3). Nectriopsis exigua has recently been synonymized as 
Nectriopsis rexiana (Sacc.) Rossman, L. Lombard & Crous, comb. nov. (MycoBank MB810977) 
(Lombard et al., 2015). Although, Nectriopsis exigua is same as Nectriopsis rexiana as accepted 
by Lombard et al. (2015). and more recently by Zare and Gams (2016), our Maximum 
Likelihood analyses with separate ITS and LSU data does show grouping of the newly obtained 
sequences of Nectriopsis rexiana by Zare and Gams (2016) with MSX53554 and strain G.J.S. 
98-32. Due to the contradiction in our analysis with those of recently published studies (Lombard 
et al., 2015, Zare and Gams, 2016), we take a more conservative approach and identify 
MSX53554 as Nectriopsis Maire (Bionectriaceae, Hypocreales, Ascomycota). The sequences 
obtained in this study were deposited in GenBank (ITS: KY471442; LSU: KY471443; tef1: 
KY471444). 
 
4.4. Fermentation, extraction, and isolation 
 
The fungal fermentations were performed using procedures reported previously (Ayers et al., 
2011, Ayers et al., 2012, El-Elimat et al., 2014, Figueroa et al., 2012). Briefly, fresh cultures 
were inoculated in a medium containing 2% soy peptone, 2% dextrose, and 1% yeast extract 
(YESD media). Following incubation (7 days) at 22 °C with agitation, the cultures were used to 
inoculate 50 ml of a rice medium, prepared using rice to which was added a vitamin solution and 
twice the volume of rice with H2O in a 250-ml Erlenmeyer flask. This was incubated at 22 °C 
until the cultures showed good growth (approximately 14 days) to generate the screening 
cultures. The one scale-up culture used for isolation of the peptaibols was grown in a 2.8 l 
Fernbach flask containing 150 g of rice and 300 ml of H2O and were inoculated using a seed 
culture grown in YESD medium. It was incubated at 22 °C for 14 days. 
 
The scale-up fungal culture was extracted using a previously reported procedure (Ayers et al., 
2011, Ayers et al., 2012, El-Elimat et al., 2014, Figueroa et al., 2012). Briefly, the culture was 
extracted by adding 500 ml of MeOH–CHCl3 (1:1) to a 2.8 l fernbach flask containing 150 g of 
rice with fungal growth. The culture was chopped with a spatula before shaking overnight 
(∼16 h) at ∼100 rpm at room temperature. Using vacuum filtration, the sample was filtered, and 
the remaining residue was washed with MeOH. To the filtrate, 900 ml of CHCl3 and 1500 ml of 
H2O were added. The mixture was stirred for 30 min and then transferred into a separatory 
funnel. The organic layer was drawn off and evaporated to dryness. The dried organic extract 
was re-constituted in 300 ml of MeOH–CH3CN (1:1) and 300 ml of hexanes and transferred to a 
separatory funnel. The biphasic solution was shaken vigorously. After settling, the MeOH–
CH3CN layer was evaporated to dryness under vacuum (480.81 mg). 
 
The dried extract was dissolved in CHCl3, adsorbed onto Celite 545, and fractionated via normal 
phase flash chromatography on a CombiFlash Rf system using a 12 g RediSep Rd Si-gel Gold 
column (Teledyne-ISCO, Lincoln, NE, USA). The gradient solvent system was hexane–CHCl3–
MeOH at a flow rate of 30 ml/min with 70.0 column volumes over 39.2 min. This afforded three 
fractions: fraction 1 (21.52 mg), fraction 2 (277.07 mg) and fraction 3 (118.55 mg). 
 
Fraction 3, the peptaibol-enriched material as noted by mass spectrometry, was dissolved in 
500 μl MeOH and purified via preparative HPLC using a gradient that initiated with 60:40 
CH3CN/H2O and increased linearly to 80:20 CH3CN/H2O over 30 min. This afforded two sub-
fractions. Sub-fraction 1 afforded compound 1 (15 mg), but sub-fraction 2 was a mixture of three 
positional isomers. The isomers were separated from each other by semi-preparative HPLC using 
an isocratic method of 40:60 CH3CN/H2O, yielding compounds 2(1.81 mg), 3 (0.44 mg), and 4 
(0.56 mg). 
 
4.5. Amino acid analysis using Marfey's reagent 
 
Compound 1 was analyzed using an optimization of a procedure we reported previously (Ayers 
et al., 2012). Briefly, to each reaction vial, approximately 0.2 mg of each amino acid standard 
was mixed with 50 μl of H2O, 20 μl of 1M NaHCO3, and 100 μl 1% Marfey's reagent ((Nα-(2,4-
dinitro-5-fluorophenyl)-L-alaninamide; Acros Organics) in acetone. The mixtures were stirred at 
40 °C for 1 h, then halted by the addition of 10 μl of 2N HCl. The product of the reactions was 
dried under a stream of air and dissolved in 2 ml of MeOH. Each derivatized standard was 
injected individually (0.7 μl) onto the UPLC-MS system. The UPLC conditions were 10–70% 
MeOH in H2O over 10 min on the aforementioned BEH column and eluent monitored at 340 nm 
(Ayers et al., 2012). 
 
Additionally, approximately 0.5 mg of compound 1 was hydrolyzed with 0.5 ml of 6N HCl in a 
reaction vial at 110 °C for 24 h. The solvent was evaporated under a stream of air. To the 
hydrolysis product, 25 μl H2O, 10 μl 1M NaHCO3, and 50 μl of 1% Marfey's reagent in acetone 
was added. The reaction mixture was agitated at 40 °C for 1 h. The reaction was quenched by the 
addition of 5 μl of 2N HCl followed by drying under a stream of air. The dried product was 
reconstituted in 200 μl of MeOH and injected onto the UPLC with the use of the same conditions 
as for the standards. 
 
4.6. Cytotoxicity bioassay 
 
Human melanoma cancer cells MDA-MB-435, human breast cancer cells MDA-MB-231, and 
human ovarian cancer cells OVCAR3 were purchased from the American Type Culture 
Collection (Manassas, VA). The cell lines were propagated at 37 °C in 5% CO2 in RPMI 1640 
medium, supplemented with fetal bovine serum (10%), penicillin (100 units/ml), and 
streptomycin (100 μg/ml) (Life Technologies, Grand Island, NY). Cells in log phase growth 
were harvested by trypsinization followed by two washes in PBS to remove all traces of the 
enzyme. A total of 5000 cells were seeded per well in a 96-well clear, flat-bottom plate 
(Microtest 96®, Falcon) and incubated overnight (37 °C in 5% CO2). Samples dissolved in 
DMSO were then diluted and added to the appropriate wells. The cells were incubated in the 
presence of test substance for 72 h at 37 °C and evaluated for viability with a commercial 
absorbance assay (CellTiter 96® AQueous One Solution Cell Proliferation Assay, Promega Corp, 
Madison, WI). IC50 values are expressed in μM relative to the solvent (DMSO) control. All IC50 
determinations were conducted with three biological replicates that were each performed in 
triplicated wells. 
 
Acknowledgments 
 
This research was supported by grant P01 CA125066 from the National Cancer 
Institute/National Institutes of Health, Bethesda, MD, USA. We thank Drs. Vilmos Kertesz and 
Gary J. Van Berkel (Mass Spectrometry and Laser Spectroscopy Group, Chemical Sciences 
Division, Oak Ridge National Laboratory) for inspiration and guidance with the droplet-LMJ-
SSP. 
 
Appendix A. Supplementary data 
 
Supplementary data related to this article can be found at 
http://dx.doi.org/10.1016/j.phytochem.2017.07.004. 
 
References 
 
Andersson, M.A., Mikkola, R., Raulio, M., Kredics, L., Maijala, P., Salkinoja-Salonen, M.S., 
2009. Acrebol, a novel toxic peptaibol produced by an Acremonium exuviarum indoor isolate. J. 
Appl. Microbiol. 106, 909e923. 
 
Ayers, S., Ehrmann, B.M., Adcock, A.F., Kroll, D.J., Carcache de Blanco, E.J., Shen, Q., 
Swanson, S.M., Falkinham, J.O., Wani, M.C., Mitchell, S.M., Pearce, C.J., Oberlies, N.H., 2012. 
Peptaibols from two unidentified fungi of the order Hypocreales with cytotoxic, antibiotic, and 
anthelmintic activities. J. Pept. Sci. 18, 500e510. 
 
Ayers, S., Graf, T.N., Adcock, A.F., Kroll, D.J., Matthew, S., Carcache de Blanco, E.J., Shen, 
Q., Swanson, S.M., Wani, M.C., Pearce, C.J., Oberlies, N.H., 2011. Resorcylic acid lactones 
with cytotoxic and NF-kB inhibitory activities and their structure-activity relationships. J. Nat. 
Prod. 74, 1126e1131. 
 
Bhushan, R., Brückner, H., 2004. Marfey's reagent for chiral amino acid analysis: a review. 
Amino Acids 27, 231e247. 
 
Bhushan, R., Brückner, H., 2011. Use of Marfey's reagent and analogs for chiral amino acid 
analysis: assessment and applications to natural products and biological systems. J. Chromatogr. 
B 879, 3148e3161. 
 
Carbone, I., Kohn, L.M., 1999. A method for designing primer sets for speciation studies in 
filamentous ascomycetes. Mycologia 91, 553e556. 
 
Degenkolb, T., Berg, A., Gams, W., Schlegel, B., Gr€afe, U., 2003. The occurrence of peptaibols 
and structurally related peptaibiotics in fungi and their mass spectrometric identification via 
diagnostic fragment ions. J. Pept. Sci. 9, 666e678. 
 
Degenkolb, T., Bruckner, H., 2008. Peptaibiomics: towards a myriad of bioactive peptides 
containing C(alpha)-dialkylamino acids? Chem. Biodivers. 5, 1817e1843. 
 
Edgar, R.C., 2004. MUSCLE: multiple sequence alignment with high accuracy and high 
throughput. Nucleic Acids Res. 32, 1792e1797. 
 
El-Elimat, T., Raja, H.A., Day, C.S., Chen, W.L., Swanson, S.M., Oberlies, N.H., 2014. 
Greensporones: resorcylic acid lactones from an aquatic Halenospora sp. J. Nat. Prod. 77, 
2088e2098. 
 
Figueroa, M., Graf, T.N., Ayers, S., Adcock, A.F., Kroll, D.J., Yang, J., Swanson, S.M., Munoz-
Acuna, U., Carcache de Blanco, E.J., Agrawal, R., Wani, M.C., Darveaux, B.A., Pearce, C.J., 
Oberlies, N.H., 2012. Cytotoxic epipolythiodioxopiperazine alkaloids from filamentous fungi of 
the Bionectriaceae. J. Antibiot. 65, 559e564. 
 
Figueroa, M., Raja, H., Falkinham, J.O., Adcock, A.F., Kroll, D.J.,Wani, M.C., Pearce, C.J., 
Oberlies, N.H., 2013. Peptaibols, tetramic acid derivatives, isocoumarins, and sesquiterpenes 
from a Bionectria sp. (MSX 47401). J. Nat. Prod. 76, 1007e1015. 
 
Gouy, M., Guindon, S., Gascuel, O., 2010. SeaView version 4: a multiplatform graphical user 
interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol. 27, 221e224. 
 
He, H., Janso, J.E., Yang, H.Y., Bernan, V.S., Lin, S.L., Yu, K., 2006. Culicinin D, an antitumor 
peptaibol produced by the fungus Culicinomyces clavisporus, strain LL-12I252. J. Nat. Prod. 69, 
736e741. 
 
Jaklitsch,W.M., Komon, M., Kubicek, C.P., Druzhinina, I.S., 2005. Hypocrea voglmayrii sp. 
nov. from the Austrian Alps represents a new phylogenetic clade in Hypocrea/Trichoderma. 
Mycologia 97, 1365e1378. 
 
Kertesz, V., Van Berkel, G.J., 2010. Liquid microjunction surface sampling coupled with high-
pressure liquid chromatography-electrospray ionization-mass spectrometry for analysis of drugs 
and metabolites in whole-body thin tissue sections. Anal. Chem. 82, 5917e5921. 
 
Kertesz, V., Van Berkel, G.J., 2013. Automated liquid microjunction surface sampling-HPLC-
MS/MS analysis of drugs and metabolites in whole-body thin tissue sections. Bioanalysis 5, 
819e826. 
 
Kertesz, V., Van Berkel, G.J., 2014. Sampling reliability, spatial resolution, spatial precision, 
and extraction efficiency in droplet-based liquid microjunction surface sampling. Rapid 
Commun. Mass Spectrom. 28, 1553e1560. 
 
Kinghorn, A.D., Carcache de Blanco, E.J., Lucas, D.M., Rakotondraibe, H.L., Orjala, J., 
Soejarto, D.D., Oberlies, N.H., Pearce, C.J., Wani, M.C., Stockwell, B.R., 
 
Burdette, J.E., Swanson, S.M., Fuchs, J.R., Phelps, M.A., Xu, L., Zhang, X., Shen, Y.Y., 2016. 
Discovery of anticancer agents of diverse natural origin. Anticancer Res. 36, 5623e5637. 
 
Kjer, J., Debbab, A., Aly, A.H., Proksch, P., 2010. Methods for isolation of marine-derived 
endophytic fungi and their bioactive secondary products. Nat. Protoc. 5, 479e490. 
 
Lombard, L., van der Merwe, N.A., Groenewald, J.Z., Crous, P.W., 2015. Generic concepts in 
nectriaceae. Stud. Mycol. 80, 189e245. 
 
Marfey, P., 1984. Determination of D-amino acids. II. Use of a bifunctional reagent, 1,5-
difluoro-2,4-dinitrobenzene. Carlsb. Res. Commun. 49, 591e596. 
 
Neumann, N.K.N., Stoppacher, N., Zeilinger, S., Degenkolb, T., Brückner, H., Schuhmacher, R., 
2015. The peptaibiotics database - a comprehensive online resource. Chem. Biodivers. 12, 
743e751. 
 
Otto, A., Laub, A., Wendt, L., Porzel, A., Schmidt, J., Palfner, G., Becerra, J., Krüger, D., 
Stadler, M., Wessjohann, L., Westermann, B., Arnold, N., 2016. Chilenopeptins A and B, 
peptaibols from the chilean Sepedonium aff. chalcipori KSH 883. J. Nat. Prod. 79, 929e938. 
 
Paguigan, N.D., Raja, H.A., Day, C.S., Oberlies, N.H., 2016. Acetophenone derivatives from a 
freshwater fungal isolate of recently described Lindgomyces madisonensis (G416). 
Phytochemistry 126, 59e65. 
 
Raja, H.A., Baker, T.R., Little, J.G., Oberlies, N.H., 2017a. DNA barcoding for identification of 
consumer-relevant mushrooms: a partial solution for product certification? Food Chem. 214, 
383e392. 
 
Raja, H.A., El-Elimat, T., Oberlies, N.H., Shearer, C.A., Miller, A.N., Tanaka, K., Hashimoto, 
A., Fournier, J., 2015. Minutisphaerales (Dothideomycetes, Ascomycota): a new order of 
freshwater ascomycetes including a new family, Minutisphaeraceae, and two new species from 
North Carolina, USA. Mycologia 107, 845e862. 
 
Raja, H.A., Miller, A.N., Pearce, C.J., Oberlies, N.H., 2017b. Fungal identification using 
molecular tools: a primer for the natural products research community. J. Nat. Prod. 80, 756e770. 
 
Rinehart Jr., K.L., Gaudioso, L.A., Moore, M.L., Pandey, R.C., Cook Jr., J.C., Barber, M., 
Sedgwick, R.D., Bordoli, R.S., Tyler, A.N., Green, B.N., 1981. Structures of eleven zervamicin 
and two emerimicin peptide antibiotics studied by fast atom bombardment mass spectrometry. J. 
Am. Chem. Soc. 103, 6517e6520. 
 
Rivera-Chávez, J., Raja, H.A., Graf, T.N., Burdette, J.E., Pearce, C.J., Oberlies, N.H., 2017. 
Biosynthesis of fluorinated peptaibols using a site-directed building block incorporation 
approach. J. Nat. Prod. 80, 1883e1892. 
 
Schiell, M., Hofmann, J., Kurz, M., Schmidt, F.R., Vertesy, L., Vogel, M., Wink, J., Seibert, G., 
2001. Cephaibols, new peptaibol antibiotics with anthelmintic properties from Acremonium 
tubakii DSM 12774. J. Antibiot. 54, 220e233. 
 
Sharman, G.J., Try, A.C., Williams, D.H., Ainsworth, A.M., Beneyto, R., Gibson, T.M., 
McNicholas, C., Renno, D.V., Robinson, N., Wood, K.A., Wrigley, S.K., 1996. Structural 
elucidation of XR586, a peptaibol-like antibiotic from Acremonium persicinum. Biochem. J. 
320, 723e728. 
 
Sica, V.P., El-Elimat, T., Oberlies, N.H., 2016a. In situ analysis of Asimina triloba (paw paw) 
plant tissues for acetogenins via the droplet-liquid microjunction-surface sampling probe coupled 
to UHPLC-PDA-HRMS/MS. Anal. Meth. 8, 6143e6149. 
 
Sica, V.P., Figueroa, M., Raja, H.A., El-Elimat, T., Darveaux, B.A., Pearce, C.J., Oberlies, N.H., 
2016b. Optimizing production and evaluating biosynthesis in situ of a herbicidal compound, 
mevalocidin, from Coniolariella sp. J. Ind. Microbiol. Biotechnol. 43, 1149e1157. 
 
Sica, V.P., Raja, H.A., El-Elimat, T., Kertesz, V., Van Berkel, G.J., Pearce, C.J., Oberlies, N.H., 
2015. Dereplicating and spatial mapping of secondary metabolites from fungal cultures in situ. J. 
Nat. Prod. 78, 1926e1936. 
 
Sica, V.P., Rees, E.R., Tchegnon, E., Bardsley, R.H., Raja, H.A., Oberlies, N.H., 2016c. Spatial 
and temporal profiling of griseofulvin production in Xylaria cubensis using mass spectrometry 
mapping. Front. Microbiol. 7, 544. 
 
Tata, A., Perez, C., Campos, M.L., Bayfield, M.A., Eberlin, M.N., Ifa, D.R., 2015. Imprint 
desorption electrospray ionization mass spectrometry imaging for monitoring secondary 
metabolites production during antagonistic interaction of fungi. Anal. Chem. 87, 12298e12305. 
 
Thirumalachar, M.J., 1968. Antiamoebin, a new antiprotozoal-anthelmintic antibiotic. I. 
Production and biological studies. Hindustan Antibiot. Bull. 10, 287e289. 
 
Toniolo, C., Brückner, H., 2007. Peptaibiotics. Chem. Biodivers. 4, 1021e1022. 
 
Toniolo, C., Brückner, H., 2009. In: Peptaibiotics: Fungal Peptides Containing adialkyl a-amino 
Acids. Wiley VCH, Zurich. 
 
Vilgalys, R., Hester, M., 1990. Rapid genetic identification and mapping of enzymatically 
amplified ribosomal DNA from several Cryptococcus species. J. Bacteriol. 172, 4238e4246. 
 
White, T.J., Bruns, T., Lee, S.H., Taylor, J.W., 1990. Amplification and direct sequencing of 
fungal ribosomal RNA genes for phylogenetics. In: Innis, M.A., Gelfand, D.H., Sninsky, J.J., 
White, T.J. (Eds.), PCR Protocols: a Guide to Methods and Application. Academic Press, New 
York, pp. 315e322. 
 
Whitmore, L., Wallace, B.A., 2004. The peptaibol database: a database for sequences and 
structures of naturally occurring peptaibols. Nucleic Acids Res. 32, D593eD594. 
 
Zare, R., Gams, W., 2016. More white verticillium-like anamorphs with erect conidiophores. 
Mycol. Prog. 15, 993e1030. 
